Familial, demyelinating sensory and motor polyneuropathy with conduction block

Muscle and Nerve

Volumn 41, Issue 4, 2010, Pages 558-562

  Scelsa, Stephen N ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Charcot marie tooth disease; Hereditary; Lewis sumner syndrome; MADSAM; Polyneuropathy

Indexed keywords

CEFTRIAXONE; DOXYCYCLINE; ISOLEUCINE; PERIPHERAL MYELIN PROTEIN 22; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA; VALINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG DOSE REDUCTION; ELECTROMYOGRAPHY; FEMALE; GENE DELETION; GENE DUPLICATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LYME DISEASE; MALE; NERVE BLOCK; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM;

ADOLESCENT; DEMYELINATING DISEASES; FEMALE; HEREDITARY SENSORY AND MOTOR NEUROPATHY; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; POLYMORPHISM, GENETIC; POLYNEUROPATHIES;

EID: 77950245794     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21558     Document Type: Article

References (18)

1. Dyck PJ, Swanson CJ, Low PA, Bartleson JD, Lambert EH. Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc 1982;57:239-246.
2. Crum BA, Sorenson EJ, Abad GA, Dyck PJ. Fulminant case of hereditary neuropathy with liability to pressure palsy. Muscle Nerve 2000;23: 979-983.
3. Mouton P, Tardieu S, Gouider R, Birouk N, Maisonobe T, Dubourg O, et al. Spectrum of clinical and electrophysiologic features in HNPP patients with the 17p11.2 deletion. Neurology 1999;52: 1440-1446.
4. Lewis RA, Sumner AJ, Shy ME. Electrophysiological features of inherited demyelinating neuropathies: a reappraisal in the era of molecular diagnosis. Muscle Nerve 2000;23:1472-1487.
5. Mitchell GW, Bosch EP, Hart MN. Response to immunosuppressive therapy in patients with hereditary motor and sensory neuropathy and associated dysimmune neuromuscular disorders. Eur Neurol 1987;27:188-196.
6. Bennett CL, Shirk AJ, Huynh HM, Street VA, Nelis E, Van Maldergem L, et al. SIMPLE mutation in demyelinating neuropathy and distribution in sciatic nerve. Ann Neurol 2004;55:713-720.
7. Meggouh F, de Visser M, Arts WF, De Coo RI, van Schaik IN, Baas F. Early onset neuropathy in a compound form of Charcot-Marie-Tooth disease. Ann Neurol 2005;57:589-591.
8. Lewis RA, Sumner AJ, Brown MJ, Asbury AK. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982;32: 958-964.
9. Saperstein DS, Amato AA, Wolfe GI, Katz JS, Nations SP, Jackson CE, et al. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve 1999;22:560-566.
10. Scelsa SN, MacGowan DJ, Mitsumoto H, Imperato T, LeValley AJ, Liu MH, et al. A pilot, double-blind, placebo-controlled trial of indinavir in patients with ALS. Neurology 2005;64:1298-1300.
11. Saifi GM, Szigeti K, Wiszniewski W, Shy ME, Krajewski K, Hausmanowa-Petrusewicz I, et al. SIMPLE mutations in Charcot-Marie-Tooth disease and the potential role of its protein product in protein degradation. Hum Mutat 2005;25:372-383.
12. Tang X, Marciano DL, Leeman SE, Amar S. LPS induces the interaction of a transcription factor, LPS-induced TNF-alpha factor, and STAT6(B) with effects on multiple cytokines. Proc Natl Acad Sci USA 2005;102:5132-5137.
13. Kimberley FC, Lobito AA, Siegel RM, Screaton GR. Falling into TRAPS - receptor misfolding in the TNF receptor 1-associated periodic fever syndrome. Arthritis Res Ther 2007;9:217.
14. Stojanov S, McDermott MF. The tumour necrosis factor receptor-associated periodic syndrome: current concepts. Expert Rev Mol Med 2005;7:1-18.
15. Ida H, Kawasaki E, Miyashita T, Tanaka F, Kamachi M, Izumi Y, et al. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus. Rheumatology (Oxford) 2004;43:1292-1299.
16. Deng H, Yang X, Jin T, Wu J, Hu LS, Chang M, et al. The role of IL-12 and TNF-alpha in AIDP and AMAN. Eur J Neurol 2008;15:1100-1105.
17. Zhang J, Dong H, Li B, Li CY, Guo L. Association of tumor necrosis factor polymorphisms with Guillain-Barre syndrome. Eur Neurol 2007;58:21-25.
18. Richez C, Blanco P, Lagueny A, Schaeverbeke T, Dehais J. Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers. Neurology 2005;64:1468-1670.